The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
8,499
Sort by:
Global Androgen Deprivation Therapy (ADT) Market Size study, by Drug Class (Antiandrogens, LHRH Agonists, LHRH Antagonist, Others), by Route of Administration (Oral, Injectable), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Regional Forecasts 2019-2026
US$ 4,950.00
Global Androgen Deprivation Therapy (ADT) Market is valued approximately at USD XX billion in 2018 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2019-...
February 2020
200 pages
Global Cell-based Assay Market Size study, by Product (Consumables, Instruments, Services), by Application (Drug Discovery, Basic Research, Other Applications), by End-User (Pharmaceutical & Biotechnological Companies, Academic & Government Institutes, Contract Research Organizations) and Regional Forecasts 2019-2026
US$ 4,950.00
Global Cell-based Assay Market is valued approximately at USD 12.97 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 7.2% over the forecast period 2019-2026. Cell-bas...
February 2020
200 pages
Hyperkalemia Market: A BCC Research Perspective
US$ 1,250.00
The goals of this study were to understand the current market scenario for hyperkalemia drugs and to assess the market’s growth potential through the end of 2022. This study explores market dynamics...
January 2020
19 pages
